Sidney Zisook, M Katherine Shear, Charles F Reynolds, Naomi M Simon, Christine Mauro, Natalia A Skritskaya, Barry Lebowitz, Yuanjia Wang, Ilanit Tal, Danielle Glorioso, Julie Loebach Wetherell, Alana Iglewicz, Donald Robinaugh, Xin Qiu
OBJECTIVE: Suffering associated with complicated grief (CG) is profound. Because suicide loss survivors are susceptible to developing CG, identifying effective treatments for suicide loss survivors with CG is a high priority. This report provides data on the acceptability and effectiveness of antidepressant medication and complicated grief therapy (CGT), a CG-targeted psychotherapy, for suicide loss survivors with CG identified by an Inventory of Complicated Grief score ≥ 30. METHODS: This is a secondary analysis of data collected from March 2010 to September 2014 for a 4-site, double-blind, placebo-controlled randomized trial comparing the effectiveness of antidepressant medication alone or in combination with CGT for participants with CG (score ≥ 30 on the Inventory of Complicated Grief) who were bereaved by suicide (SB; n = 58), accident/homicide (A/H; n = 74), or natural causes (NC; n = 263)...
March 13, 2018: Journal of Clinical Psychiatry